← 返回首页
美国 · 平台与数据 · Yahoo Finance

Stoke Therapeutics Inc (STOK) Q3 2026 Earnings Call Highlights: Strong Cash Runway and Phase 3 ...

来源:Yahoo Finance · 美国 8 小时前

Stoke Therapeutics Inc (STOK) ended Q3 2026 with $358.8 million in cash to fund operations into early 2028, while advancing its Phase 3 EMPEROR study toward top-line data expected…

在 Yahoo Finance 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (finance.yahoo.com)

推荐阅读